Literature DB >> 32946039

Wake-Promoting Effect of Bloodletting Puncture at Hand Twelve Jing-Well Points in Acute Stroke Patients: A Multi-center Randomized Controlled Trial.

Nan-Nan Yu1,2, Zhi-Fang Xu2,3, Yang Gao4, Zhi-Liang Zhou5, Xue Zhao2,3, Dan Zhou2,3, Zhen-Guo Wang6, Ze-Lin Chen2,3, Xing-Fang Pan7,8, Yi Guo9,10.   

Abstract

OBJECTIVE: To assess the effect and safety of bloodletting puncture at hand twelve Jing-Well points (HTWPs) in acute stroke patients with conscious disturbance.
METHODS: In this multi-center and randomized controlled trial, 360 patients suffered from ischemic or hemorrhagic stroke with conscious disturbance within 48 h from the onset of symptom were divided into bloodletting (180 cases) and control (180 cases) groups using a block randomization. Patients in both groups received routine Western medicine, and patients in the bloodletting group received additional bloodletting puncture at HTWPs on admission immediately before conventional treatment. The primary outcome measure was Glasgow Coma Scale (GCS) score and the secondary outcomes included blood pressure, respiratory rate and pulse rate. All variables were evaluated at baseline (before bloodletting), 0 (after bloodletting immediately), 15, 30, 50 and 80 min post bloodletting.
RESULTS: At 80 min post bloodletting, the proportion of patients with improved consciousness in the bloodletting group was greater than the control group (P<0.05). In the separate analysis of moderate consciousness disturbance subgroup, bloodletting therapy benefited ischemic patients, and improved the eye and language response of GCS score at 15, 30, 50, 80 min post bloodletting (P<0.05 or P<0.01). No significant differences were observed regarding the secondary outcomes between two groups (P>0.05).
CONCLUSION: The bloodletting puncture at HTWPs was safe and could improve conscious levels of ischemic stroke patients, highlighting a first-aid intervention for acute stroke. (Registration No. ChiCTR-INR-16009530).
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Glasgow Coma Scale; Jing-Well point; acute stroke; bloodletting; conscious disturbance; randomized controlled trial

Year:  2020        PMID: 32946039     DOI: 10.1007/s11655-020-3093-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  33 in total

1.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

2.  Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke.

Authors:  M Grond; J Rudolf; S Schmülling; C Stenzel; M Neveling; W D Heiss
Journal:  Arch Neurol       Date:  1998-04

3.  Initial Glasgow Coma Scale score predicts outcome following thrombolysis for posterior circulation stroke.

Authors:  Jack W Tsao; J Claude Hemphill; S Claiborne Johnston; Wade S Smith; David C Bonovich
Journal:  Arch Neurol       Date:  2005-07

4.  Thrombolysis on ischemic stroke patients with decreased level of consciousness within 4.5 h.

Authors:  Cong Chen; Min Ye; Bei-Lei Chen; Guo-Fang Chen; Zhi-Qiang Gao; Jun-Shan Zhou; Qian-Tao Cheng; Ming-Hua Wu; Mei-Juan Zhang; Lai Qian; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2012-11-20       Impact factor: 5.243

Review 5.  Stroke in China: epidemiology, prevention, and management strategies.

Authors:  Ming Liu; Bo Wu; Wen-Zhi Wang; Li-Ming Lee; Shi-Hong Zhang; Ling-Zhi Kong
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

6.  Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey.

Authors:  D L Morris; W Rosamond; K Madden; C Schultz; S Hamilton
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

7.  Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry.

Authors:  Barbara Voetsch; L Dana DeWitt; Michael S Pessin; Louis R Caplan
Journal:  Arch Neurol       Date:  2004-04

8.  Prehospital delay after acute stroke in Kaohsiung, Taiwan.

Authors:  Ku-Chou Chang; Mei-Chiun Tseng; Teng-Yeow Tan
Journal:  Stroke       Date:  2004-02-12       Impact factor: 7.914

Review 9.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

10.  Prediction of early mortality after acute stroke.

Authors:  Patricia Braga; Alicia Ibarra; Isabel Rega; Carlos Ketzoian; Matías Pebet; Liliana Servente; Daniela Benzano
Journal:  J Stroke Cerebrovasc Dis       Date:  2002 Jan-Feb       Impact factor: 2.136

View more
  2 in total

1.  Characteristics of five-phase acupoints from data mining of randomized controlled clinical trials followed by multidimensional scaling.

Authors:  Seoyoung Lee; Yeonhee Ryu; Hi-Joon Park; In-Seon Lee; Younbyoung Chae
Journal:  Integr Med Res       Date:  2021-12-22

2.  Association between Blood Donation and Malignant and Benign Tumour Risk: A Population-Based Study of 3.4 Million Participants in China.

Authors:  Shu Su; Ting Ma; Yang Sun; Lingxia Guo; Xiaodong Su; Wenhua Wang; Xinxin Xie; Liqin Wang; Lili Xing; Leilei Zhang; Shiyi He; Jiangcun Yang; Lei Zhang
Journal:  J Oncol       Date:  2022-07-08       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.